Tasly Pharmaceutical Group Co., Ltd (600535.SS)
CNY 15.16
(-0.72%)
CNY 15.16
(-0.72%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -1.49 Billion CNY | -57.88% |
| 2022 | -944.54 Million CNY | -54.76% |
| 2021 | -610.31 Million CNY | -174.57% |
| 2020 | 818.49 Million CNY | -86.8% |
| 2019 | 6.19 Billion CNY | -3.32% |
| 2018 | 6.41 Billion CNY | -4.94% |
| 2017 | 6.74 Billion CNY | 263.04% |
| 2016 | 1.85 Billion CNY | -31.27% |
| 2015 | 2.7 Billion CNY | -15.15% |
| 2014 | 3.18 Billion CNY | 79.55% |
| 2013 | 1.77 Billion CNY | 1179.48% |
| 2012 | -164.37 Million CNY | 43.45% |
| 2011 | -290.67 Million CNY | 49.4% |
| 2010 | -574.42 Million CNY | -221.52% |
| 2009 | 472.68 Million CNY | 49.11% |
| 2008 | 317 Million CNY | -2.98% |
| 2007 | 326.74 Million CNY | 523.27% |
| 2006 | -77.19 Million CNY | -168.02% |
| 2005 | 113.48 Million CNY | 14.53% |
| 2004 | 99.08 Million CNY | 139.93% |
| 2003 | -248.13 Million CNY | 61.88% |
| 2002 | -651 Million CNY | -578.68% |
| 2001 | 135.99 Million CNY | 536.57% |
| 2000 | 21.36 Million CNY | 205.43% |
| 1999 | -20.26 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -710.9 Million CNY | 24.93% |
| 2024 Q3 | -2.39 Billion CNY | -237.32% |
| 2024 Q1 | -946.94 Million CNY | 36.5% |
| 2023 Q2 | -587.2 Million CNY | -616.59% |
| 2023 Q3 | -876.8 Million CNY | -49.32% |
| 2023 Q4 | -1.49 Billion CNY | -70.07% |
| 2023 FY | -1.49 Billion CNY | -57.88% |
| 2023 Q1 | 113.67 Million CNY | 112.03% |
| 2022 Q1 | -636.49 Million CNY | -4.29% |
| 2022 FY | -944.54 Million CNY | -54.76% |
| 2022 Q4 | -944.54 Million CNY | -319.67% |
| 2022 Q3 | 429.98 Million CNY | 223.04% |
| 2022 Q2 | -349.48 Million CNY | 45.09% |
| 2021 Q3 | -557.89 Million CNY | -77.31% |
| 2021 Q1 | 486.6 Million CNY | -40.55% |
| 2021 FY | -610.31 Million CNY | -174.57% |
| 2021 Q2 | -314.64 Million CNY | -164.66% |
| 2021 Q4 | -610.31 Million CNY | -9.4% |
| 2020 Q4 | 818.49 Million CNY | -55.24% |
| 2020 FY | 818.49 Million CNY | -86.8% |
| 2020 Q1 | 6.16 Billion CNY | -0.61% |
| 2020 Q2 | 5.42 Billion CNY | -11.93% |
| 2020 Q3 | 1.82 Billion CNY | -66.3% |
| 2019 Q2 | 6.48 Billion CNY | 1.62% |
| 2019 Q4 | 6.19 Billion CNY | -2.88% |
| 2019 Q3 | 6.38 Billion CNY | -1.55% |
| 2019 Q1 | 6.38 Billion CNY | -0.49% |
| 2019 FY | 6.19 Billion CNY | -3.32% |
| 2018 Q1 | 7.15 Billion CNY | 6.0% |
| 2018 FY | 6.41 Billion CNY | -4.94% |
| 2018 Q4 | 6.41 Billion CNY | 10.91% |
| 2018 Q3 | 5.78 Billion CNY | -16.67% |
| 2018 Q2 | 6.93 Billion CNY | -2.98% |
| 2017 Q3 | 6.84 Billion CNY | 46.37% |
| 2017 FY | 6.74 Billion CNY | 263.04% |
| 2017 Q1 | 3.75 Billion CNY | 102.08% |
| 2017 Q2 | 4.67 Billion CNY | 24.54% |
| 2017 Q4 | 6.74 Billion CNY | -1.45% |
| 2016 Q3 | 1.91 Billion CNY | 87.8% |
| 2016 Q2 | 1.02 Billion CNY | -39.06% |
| 2016 Q4 | 1.85 Billion CNY | -3.01% |
| 2016 Q1 | 1.67 Billion CNY | -38.08% |
| 2016 FY | 1.85 Billion CNY | -31.27% |
| 2015 FY | 2.7 Billion CNY | -15.15% |
| 2015 Q4 | 2.7 Billion CNY | -2.55% |
| 2015 Q3 | 2.77 Billion CNY | -12.17% |
| 2015 Q2 | 3.15 Billion CNY | 21.92% |
| 2015 Q1 | 2.59 Billion CNY | -18.69% |
| 2014 Q2 | 3.59 Billion CNY | 40.62% |
| 2014 FY | 3.18 Billion CNY | 79.55% |
| 2014 Q1 | 2.55 Billion CNY | 44.07% |
| 2014 Q4 | 3.18 Billion CNY | -12.2% |
| 2014 Q3 | 3.62 Billion CNY | 0.94% |
| 2013 Q3 | 1.32 Billion CNY | 31.83% |
| 2013 Q2 | 1 Billion CNY | 1527.17% |
| 2013 FY | 1.77 Billion CNY | 1179.48% |
| 2013 Q4 | 1.77 Billion CNY | 34.29% |
| 2013 Q1 | -70.23 Million CNY | 57.27% |
| 2012 Q1 | -342.28 Million CNY | -17.76% |
| 2012 Q2 | -240.59 Million CNY | 29.71% |
| 2012 FY | -164.37 Million CNY | 43.45% |
| 2012 Q3 | -87.14 Million CNY | 63.78% |
| 2012 Q4 | -164.37 Million CNY | -88.63% |
| 2011 FY | -290.67 Million CNY | 49.4% |
| 2011 Q4 | -290.67 Million CNY | -539.02% |
| 2011 Q3 | -45.48 Million CNY | 47.38% |
| 2011 Q2 | -86.44 Million CNY | 72.74% |
| 2011 Q1 | -317.12 Million CNY | 44.79% |
| 2010 Q2 | 665.19 Million CNY | 47.78% |
| 2010 Q3 | 591.22 Million CNY | -11.12% |
| 2010 Q1 | 450.13 Million CNY | -4.77% |
| 2010 Q4 | -574.42 Million CNY | -197.16% |
| 2010 FY | -574.42 Million CNY | -221.52% |
| 2009 Q2 | 331.92 Million CNY | 4.29% |
| 2009 Q4 | 472.68 Million CNY | 12.32% |
| 2009 Q1 | 318.28 Million CNY | 0.4% |
| 2009 FY | 472.68 Million CNY | 49.11% |
| 2009 Q3 | 420.83 Million CNY | 26.79% |
| 2008 Q4 | 317 Million CNY | -35.1% |
| 2008 FY | 317 Million CNY | -2.98% |
| 2008 Q1 | 465.5 Million CNY | 42.47% |
| 2008 Q2 | 523.27 Million CNY | 12.41% |
| 2008 Q3 | 488.42 Million CNY | -6.66% |
| 2007 FY | 326.74 Million CNY | 523.27% |
| 2007 Q4 | 326.74 Million CNY | 28.13% |
| 2007 Q3 | 255.01 Million CNY | 196.03% |
| 2007 Q2 | -265.57 Million CNY | 3.45% |
| 2007 Q1 | -275.04 Million CNY | -256.3% |
| 2006 Q3 | 347.4 Million CNY | 145.93% |
| 2006 Q4 | -77.19 Million CNY | -122.22% |
| 2006 Q2 | 141.25 Million CNY | 38.59% |
| 2006 FY | -77.19 Million CNY | -168.02% |
| 2006 Q1 | 101.92 Million CNY | -10.18% |
| 2005 Q4 | 113.48 Million CNY | -44.7% |
| 2005 FY | 113.48 Million CNY | 14.53% |
| 2005 Q1 | 44.69 Million CNY | -54.89% |
| 2005 Q2 | 169.26 Million CNY | 278.68% |
| 2005 Q3 | 205.21 Million CNY | 21.24% |
| 2004 Q1 | -224.41 Million CNY | 9.56% |
| 2004 Q4 | 99.08 Million CNY | 340.45% |
| 2004 Q3 | -41.21 Million CNY | 74.95% |
| 2004 Q2 | -164.53 Million CNY | 26.68% |
| 2004 FY | 99.08 Million CNY | 139.93% |
| 2003 Q1 | -597.67 Million CNY | 8.19% |
| 2003 Q2 | -386.52 Million CNY | 35.33% |
| 2003 FY | -248.13 Million CNY | 61.88% |
| 2003 Q3 | -368.07 Million CNY | 4.77% |
| 2003 Q4 | -248.13 Million CNY | 32.59% |
| 2002 FY | -651 Million CNY | -578.68% |
| 2002 Q2 | 104.8 Million CNY | 0.0% |
| 2002 Q4 | -651 Million CNY | -2.65% |
| 2002 Q3 | -634.18 Million CNY | -705.12% |
| 2001 FY | 135.99 Million CNY | 536.57% |
| 2000 FY | 21.36 Million CNY | 205.43% |
| 1999 FY | -20.26 Million CNY | 0.0% |